Lung Cancer | Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers - a podcast by Dr Neil Love

from 2021-12-14T14:44

:: ::

Featuring perspectives from Drs Marc Ladanyi, Andrew McKenzie and Joel Neal, including the following topics:

  • Introduction (0:00)
  • Role of Genomic Profiling; New Developments in Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:49)
  • Case: A woman in her early 60s with NSCLC and an EGFR exon 19 deletion — Andrew J McKenzie, PhD (30:40)
  • Case: A man in his early 50s with metastatic lung adenocarcinoma and an EGFR exon 20 mutation — Atif Hussein, MD, MMM (35:04)
  • Case: A man in his early 50s with RET positive NSCLC — Joel W Neal, MD, PhD (48:48)
  • Case: A woman in her mid-60s with metastatic NSCLC and a HER2 exon 20 insertion — Dr Neal 

CME information and select publications

Further episodes of Research To Practice | Oncology Videos

Further podcasts by Dr Neil Love

Website of Dr Neil Love